Two Sigma Securities’s Antares Pharma, Inc. ATRS Stock Holding History

Two Sigma Securities’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-12,949	Closed	-$39K	–	2524
2019 Q1	$39K	Buy	+12,949	New	+$42K	﹤0.01%	1634
2017 Q4	–	Sell	-16,633	Closed	-$54K	–	2097
2017 Q3	$54K	Buy	+16,633	New	+$51.3K	﹤0.01%	736
2016 Q3	–	Sell	-20,609	Closed	-$22K	–	820
2016 Q2	$22K	Buy	+20,609	New	+$19.9K	0.01%	370

Other funds holding ATRS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Two Sigma Securities's ATRS Position: Q2 2019 in Review

Two Sigma Securities sold out of Antares Pharma, Inc. (ATRS) in Q2 2019, closing a stake of 12,949 shares — an estimated $39K sold.

Two Sigma Securities first reported a position in ATRS in Q2 2016 and held it in 3 quarters. The position peaked at $54K in Q3 2017. 127 funds tracked by Wall St. Rank hold ATRS as of Q2 2019.

Two Sigma Securities reported no remaining Antares Pharma, Inc. position as of Q2 2019 after selling out during the quarter.
Two Sigma Securities sold 12,949 Antares Pharma, Inc. shares in Q2 2019, an estimated $39K.
Two Sigma Securities first reported a position in Antares Pharma, Inc. in Q2 2016 and held it in 3 quarters.
Two Sigma Securities's Antares Pharma, Inc. position peaked at $54K in Q3 2017.
127 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2019.

Based on Two Sigma Securities's 13F filing for Q2 2019, filed 14 Aug 2019.